Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning
Science Advances · 30.05.2025 · 11 (22)
DOI: 10.1126/sciadv.ads7187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 30.05.2025. Verfasst von Galen J Correy und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Coronavirus 3C Proteases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
The macrodomain of severe acute respiratory syndrome coronavirus 2 nonstructural protein 3 is required for viral pathogenesis and is an emerging antiviral target. We previously performed an x-ray crystallography–based fragment screen and found submicromolar inhibitors by fragment linking. However, these compounds had poor membrane permeability and liabilities that complicated optimization. Here, we developed a shape-based virtual screening pipeline—FrankenROCS. We screened the Enamine high-throughput collection of 2.1 million compounds, selecting 39 compounds for testing, with the most potent binding with a 130 μM median inhibitory concentration (IC 50 ). We then paired FrankenROCS with an active learning algorithm (Thompson sampling) to efficiently search the Enamine REAL database of 22 billion molecules, testing 32 compounds with the most potent binding with a 220 μM IC 50 . Further optimization led to analogs with IC 50 values better than 10 μM. This lead series has improved membrane permeability and is poised for optimization. FrankenROCS is a scalable method for fragment linking to exploit synthesis-on-demand libraries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158, USA.
- Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158, USA.
- Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158, USA.
- Relay Therapeutics, Cambridge, MA 02142, USA.
- Enamine Ltd., Kyiv, Ukraine.
- Chemspace LLC, Kyiv, Ukraine.
ORCID-Profile: Galen J Correy, Moira M Rachman, Takaya Togo, Stefan Gahbauer, Yagmur U Doruk, Maisie G V Stevens, Priyadarshini Jaishankar, Brian Goldman, Trevor Kramer, Dmytro S Radchenko, Yurii S Moroz, Alan Ashworth, Patrick Riley, Brian K Shoichet, Adam R Renslo, W Patrick Walters, James S Fraser
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Correy, G. J., Rachman, M. M., Togo, T., Gahbauer, S., Doruk, Y. U., Stevens, M. G. V., Jaishankar, P., Kelley, B., Goldman, B., Schmidt, M., Kramer, T., Radchenko, D. S., Moroz, Y. S., Ashworth, A., Riley, P., Shoichet, B. K., Renslo, A. R., Walters, W. P., & Fraser, J. S. (2025). Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning. Science Advances, 11(22). https://doi.org/10.1126/sciadv.ads7187
Vancouver
Correy GJ, Rachman MM, Togo T, Gahbauer S, Doruk YU, Stevens MGV, et al. Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning. Science Advances. 2025;11(22). doi:10.1126/sciadv.ads7187
BibTeX
@article{Correy2025,
author = {Correy, Galen J and Rachman, Moira M and Togo, Takaya and Gahbauer, Stefan and Doruk, Yagmur U and Stevens, Maisie G V and Jaishankar, Priyadarshini and Kelley, Brian and Goldman, Brian and Schmidt, Molly and Kramer, Trevor and Radchenko, Dmytro S and Moroz, Yurii S and Ashworth, Alan and Riley, Patrick and Shoichet, Brian K and Renslo, Adam R and Walters, W Patrick and Fraser, James S},
title = {Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {22},
doi = {10.1126/sciadv.ads7187}
}
EUVIMED